Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Discovery and Characterization of a High Potency Anti-Inflammatory Trispecific TNFα/IL-17A/IL-17F Inhibitor
1. APRIL 29, 2016
PEGS, BOSTON
DISCOVERY AND CHARACTERIZATION OF
A HIGH POTENCY ANTI-INFLAMMATORY
TRISPECIFIC TNF⍺/IL-17A/IL-17F INHIBITOR
2. AUTHORS
S. AGEEV
A. ULITIN
E. ZUBAREVA
I. USTUGOV
D. KORZHAVIN
E. LOMKOVA
V. SOLOVJEV
E. SOFRONOVA
V. EKIMOVA
A. ALEXANDROV
A. KARABELSKY
Y. BASOVSKIY
V. USATOVA
T. CHERNOVSKAYA
E. MOROZOVA
A. GRACHEV
R. IVANOV
D. MOROZOV
PRESENTER:
PAVEL YAKOVLEV
APRIL 29, 2016
PEGS, BOSTON
3. APRIL 29, 2016
PEGS, BOSTON
BCD 121
OctetRED96 measurement demonstrated that BCD 121
is capable to simultaneous non-completitive IL-17A
and TNF ligand binding.
Blue lines — added 1 mkg/ml TNFa
Red and green — without TNFa